Education
About Us
Working with TipRanks
Follow Us
Intervacc AB (DE:2E9)
FRANKFURT:2E9
Comparison Results
IRLAB Therapeutics AB Class A
kr2.98
kr253.12M
―
-73.91%
0 Buy
0 Hold
0 Sell
Moderate Sell
Performance Comparison
DE:2E9
Intervacc AB
0.04
-0.19
-82.61%
SE:XBRANE
Xbrane Biopharma AB
0.25
0.06
29.74%
SE:ELIC
Elicera Therapeutics AB
4.85
3.26
204.08%
SE:ACE
Ascelia Pharma AB
3.47
1.24
56.08%
SE:IRLAB.A
IRLAB Therapeutics AB Class A
2.98
-9.01
-75.15%
SE:IMMU
Immunicum AB
6.70
-1.38
-17.09%